Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: A comparative study by alternative free-response receiver operating characteristic analysis

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 120-124

  Tanimoto, Akihiro ^a   Satoh, Yoshinori ^a   Yuasa, Yuji ^a   Jinzaki, Masahiro ^a   Hiramatsu, Kyoichi ^a  

^a KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Contrast media, gadolinium, iron, magnetic resonance; Diagnosis, magnetic resonance; Experimental, liver; Magnetic resonance; Neoplasm

Indexed keywords

GADOLINIUM PENTETATE DERIVATIVE; GADOXETIC ACID; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; LIVER CANCER; LIVER TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; TUMOR VOLUME;

ANIMALS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; FEMALE; FERRIC COMPOUNDS; GADOLINIUM DTPA; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; RATS; RATS, INBRED STRAINS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0031421927     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070116     Document Type: Article

References (22)

1. Fujita M, Yamamoto R, Fritz-Zieroth B, et al. Contrast enhancement with Gd-EOB-DTPA in MR Imaging of hepatocellular carcinoma in mice: a comparison with superparamagnetic iron oxide. JMRI 1996; 6:472-477.
2. Starr SJ, Metz CE, Lusted LB, et al. Visual detection and localization of radiographic images. Radiology 1975; 116:533-538.
3. Chakraborty DP, Winter LH. Free-response methodology: alternate analysis and a new observer-performance experiment. Radiology 1990; 174:873-881.
4. Chakraborty DP. Maximum likelihood analysis of free-response receiver operating characteristic (FROC) data. Med Phys 1989; 16:561-568.
5. Farber E. Similarities in the sequence of early histological changes in the liver of the rat by ethionine, 2-acetylaminofluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res 1956; 16:142-148.
6. Kawamori Y, Matsui O, Kadoya M, Yoshikawa J, Demachi H, Takashima T. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology 1992; 183:65-72.
7. Schuhmann-Gaimpieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183:59-64.
8. Hamm B, Stacks T, Müller A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195:785-792.
9. Reimer P, Rummeny EJ, Daldrup HE, et al. Clinical results with Resovist: a phase 2 clinical trial. Radiology 1995; 195:489-496.
10. Yamamoto H, Yamashita Y, Yoshimatsu S, et al. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging. Radiology 1995; 195: 106-112.
11. Hagspiel KD, Neidl KFW, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196:471-478.
12. Senéterre E, Vergnes C, Taourel P, et al. CT arterial portography (CTAP) versus superparamagnetic iron oxide enhanced MR for screening of hepatic metastases. In: Book of abstracts: Society of Magnetic Resonance 1995. Nice: Society of Magnetic Resonance, 1995; 403.
13. Denys A, Arrive L, Servois V, et al. Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25. Radiology 1994; 193:665-669.
14. Ni Y, Marchal G, Yu J, Mühler A, Lukito G, Baert AL. Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization. JMRI 1994; 4:355-363.
15. Matsui O, Kadoya M, Kameyama T, et al. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging. Radiology 1989; 173: 123-126.
16. Vogl TJ, Kümmell S, Hammerstingl R, et al. Enhancement of HCC and liver metastases versus FNH and hemangiomas using Gd-EOB-DTPA and Gd-DTPA enhanced MRI in the same patient. In: Book of abstracts: Society of Magnetic Resonance 1995. Nice: Society of Magnetic Resonance, 1995; 293.
17. Grandin C, Van Beers BE, Robert A, Gigot J-F, Geubel A, Pringot J. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 1995; 9:412-418.
18. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198:881-887.
19. Low RN, Francis IR, Sigeti JS, Foo TKF. Abdominal MR Imaging: comparison of T2-weighted fast and conventional spin-echo, and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging. Radiology 1993; 186:803-811.
20. Soyer P, Normand SL, Givry SC, Gueye C, Somveille E, Scherrer A. T2-weighted spin-echo MR Imaging of the liver: breath-hold fast spin-echo versus non-breath-hold fast spin-echo images with and without fat suppression. AJR 1996; 166:593-597.
21. Reimer P, Rummeny EJ, Shamsi K, et al. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 1996; 199:177-183.
22. Schwartz LH, Seltzer SE, Adams DF, et al. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequence. Invest Radiol 1994; 29:S21-S23.